Related Experiment Video
Updated: Aug 19, 2026

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus (MRSA)
Published on: February 9, 2011
Genetic basis of neonatal methicillin-resistant Staphylococcus aureus in Japan
1Department of Infectious Diseases, Tokyo Women's Medical University, Tokyo, Japan. kikuti@clabo.zengaku.twmu.ac.jp
Abstract:
Methicillin-resistant Staphylococcus aureus (MRSA) is still one of major problems of drug-resistant microorganisms and healthcare-acquired infections. Methicillin-resistant Staphylococcus aureus is highly prevalent in patients in neonatal intensive care units (NICU) in Japan. The most predominant MRSA in NICU is multidrug resistant and produces superantigenic exotoxin, toxic shock syndrome toxin-1 (TSST-1) and staphylococcal enterotoxin C (SEC). These predominant MRSA strains belong to coagulase type II, SCCmec type II, mecA-Tn554 polymorph type I-A and show closely related pulse field gel electrophoresis types. The dissemination of MRSA is wide, and there is a pandemic distribution of a single MRSA clone in the NICU of Japan. Since 1992, the nationwide spread of this clone has also led to the development of a new neonatal disease known as neonatal toxic shock-like exanthematous disease (NTED), which is caused by overactivation of vbeta2+ T cells induced by TSST-1. The spread of MRSA in NICU in Japan has been attributed to overcrowding, high rates of extremely low birthweight babies, understaffing, low control measures of infection and overuse of antibiotics. The environment of NICU and infection control intervention should be improved and a new strategy for control like vaccination or probiotics is required.
Insights
A dominant multidrug-resistant Methicillin-resistant Staphylococcus aureus (MRSA) clone causes neonatal toxic shock-like exanthematous disease (NTED) in Japanese NICUs. Improved infection control and new strategies like vaccination are crucial for combating this healthcare-associated infection.
Area of Science:
- Medical Microbiology
- Infectious Diseases
- Neonatal Care
Background:
- Methicillin-resistant Staphylococcus aureus (MRSA) poses a significant global challenge as a drug-resistant pathogen, particularly in healthcare settings.
- MRSA infections are highly prevalent in Japanese neonatal intensive care units (NICUs), with a predominant multidrug-resistant clone identified.
Purpose of the Study:
- To investigate the characteristics and epidemiology of MRSA strains circulating in Japanese NICUs.
- To understand the clinical impact of MRSA, including the emergence of neonatal toxic shock-like exanthematous disease (NTED).
Main Methods:
- Characterization of MRSA strains using molecular typing methods (coagulase type, SCCmec type, mecA-Tn554 polymorph type, pulse field gel electrophoresis).
- Epidemiological analysis of MRSA dissemination and association with NTED development.
Main Results:
- A single, pandemic MRSA clone (coagulase type II, SCCmec type II, mecA-Tn554 polymorph type I-A) is widely disseminated in Japanese NICUs.
- This clone produces toxic shock syndrome toxin-1 (TSST-1) and staphylococcal enterotoxin C (SEC), leading to NTED through T cell overactivation.
- Factors contributing to MRSA spread include NICU overcrowding, high rates of extremely low birthweight infants, understaffing, inadequate infection control, and antibiotic overuse.
Conclusions:
- The findings highlight a critical MRSA epidemic in Japanese NICUs driven by a specific clone, necessitating urgent intervention.
- There is a clear need for enhanced NICU environments, improved infection control measures, and novel control strategies such as vaccination or probiotics to combat MRSA and NTED.
Related Concept Videos
Mismatch Repair
Development of the Oral Microbiota
Staphylococcal Skin Infections
Mechanism of Antibiotic Resistance in MRSA
Clinical Significance of Antibiotic Resistance

